Skip to main content
PMC home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1997 Jun;17(6):3418–3428. doi: 10.1128/mcb.17.6.3418

Tumor promotion by depleting cells of protein kinase C delta.

Z Lu 1, A Hornia 1, Y W Jiang 1, Q Zang 1, S Ohno 1, D A Foster 1
PMCID: PMC232195  PMID: 9154841

Abstract

Tumor-promoting phorbol esters activate, but then deplete cells of, protein kinase C (PKC) with prolonged treatment. It is not known whether phorbol ester-induced tumor promotion is due to activation or depletion of PKC. In rat fibroblasts overexpressing the c-Src proto-oncogene, the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) induced anchorage-independent growth and other transformation-related phenotypes. The appearance of transformed phenotypes induced by TPA in these cells correlated not with activation but rather with depletion of expressed PKC isoforms. Consistent with this observation, PKC inhibitors also induced transformed phenotypes in c-Src-overexpressing cells. Bryostatin 1, which inhibited the TPA-induced down-regulation of the PKCdelta isoform specifically, blocked the tumor-promoting effects of TPA, implicating PKCdelta as the target of the tumor-promoting phorbol esters. Consistent with this hypothesis, expression of a dominant negative PKCdelta mutant in cells expressing c-Src caused transformation of these cells, and rottlerin, a protein kinase inhibitor with specificity for PKCdelta, like TPA, caused transformation of c-Src-overexpressing cells. These data suggest that the tumor-promoting effect of phorbol esters is due to depletion of PKCdelta, which has an apparent tumor suppressor function.

Full Text

The Full Text of this article is available as a PDF (2.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boegheim J. P., Dubbelman T. M., Mullenders L. H., Van Steveninck J. Photodynamic effects of haematoporphyrin derivative on DNA repair in murine L929 fibroblasts. Biochem J. 1987 Jun 15;244(3):711–715. doi: 10.1042/bj2440711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borner C., Ueffing M., Jaken S., Parker P. J., Weinstein I. B. Two closely related isoforms of protein kinase C produce reciprocal effects on the growth of rat fibroblasts. Possible molecular mechanisms. J Biol Chem. 1995 Jan 6;270(1):78–86. doi: 10.1074/jbc.270.1.78. [DOI] [PubMed] [Google Scholar]
  3. Chin J. E., Dickens M., Tavare J. M., Roth R. A. Overexpression of protein kinase C isoenzymes alpha, beta I, gamma, and epsilon in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. J Biol Chem. 1993 Mar 25;268(9):6338–6347. [PubMed] [Google Scholar]
  4. Clark E. A., Brugge J. S. Redistribution of activated pp60c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets. Mol Cell Biol. 1993 Mar;13(3):1863–1871. doi: 10.1128/mcb.13.3.1863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Couldwell W. T., Hinton D. R., He S., Chen T. C., Sebat I., Weiss M. H., Law R. E. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett. 1994 May 23;345(1):43–46. doi: 10.1016/0014-5793(94)00415-3. [DOI] [PubMed] [Google Scholar]
  6. Daub H., Weiss F. U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 1996 Feb 8;379(6565):557–560. doi: 10.1038/379557a0. [DOI] [PubMed] [Google Scholar]
  7. Decker S. J. Effects of epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate on metabolism of the epidermal growth factor receptor in normal human fibroblasts. Mol Cell Biol. 1984 Sep;4(9):1718–1724. doi: 10.1128/mcb.4.9.1718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Decker S. J. Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites. J Biol Chem. 1993 May 5;268(13):9176–9179. [PubMed] [Google Scholar]
  9. Denning M. F., Dlugosz A. A., Howett M. K., Yuspa S. H. Expression of an oncogenic rasHa gene in murine keratinocytes induces tyrosine phosphorylation and reduced activity of protein kinase C delta. J Biol Chem. 1993 Dec 15;268(35):26079–26081. [PubMed] [Google Scholar]
  10. Denning M. F., Dlugosz A. A., Threadgill D. W., Magnuson T., Yuspa S. H. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta. J Biol Chem. 1996 Mar 8;271(10):5325–5331. doi: 10.1074/jbc.271.10.5325. [DOI] [PubMed] [Google Scholar]
  11. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther. 1992;54(1):63–128. doi: 10.1016/0163-7258(92)90051-z. [DOI] [PubMed] [Google Scholar]
  12. Downward J., Waterfield M. D., Parker P. J. Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. J Biol Chem. 1985 Nov 25;260(27):14538–14546. [PubMed] [Google Scholar]
  13. Friedman B., Frackelton A. R., Jr, Ross A. H., Connors J. M., Fujiki H., Sugimura T., Rosner M. R. Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor. Proc Natl Acad Sci U S A. 1984 May;81(10):3034–3038. doi: 10.1073/pnas.81.10.3034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gschwendt M., Müller H. J., Kielbassa K., Zang R., Kittstein W., Rincke G., Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun. 1994 Feb 28;199(1):93–98. doi: 10.1006/bbrc.1994.1199. [DOI] [PubMed] [Google Scholar]
  15. Hennings H., Blumberg P. M., Pettit G. R., Herald C. L., Shores R., Yuspa S. H. Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis. 1987 Sep;8(9):1343–1346. doi: 10.1093/carcin/8.9.1343. [DOI] [PubMed] [Google Scholar]
  16. Hill T. D., Dean N. M., Mordan L. J., Lau A. F., Kanemitsu M. Y., Boynton A. L. PDGF-induced activation of phospholipase C is not required for induction of DNA synthesis. Science. 1990 Jun 29;248(4963):1660–1663. doi: 10.1126/science.2163545. [DOI] [PubMed] [Google Scholar]
  17. Hirai S., Izumi Y., Higa K., Kaibuchi K., Mizuno K., Osada S., Suzuki K., Ohno S. Ras-dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKC delta. EMBO J. 1994 May 15;13(10):2331–2340. doi: 10.1002/j.1460-2075.1994.tb06517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jarvis W. D., Turner A. J., Povirk L. F., Traylor R. S., Grant S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 1994 Apr 1;54(7):1707–1714. [PubMed] [Google Scholar]
  19. Jiang H., Luo J. Q., Urano T., Frankel P., Lu Z., Foster D. A., Feig L. A. Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature. 1995 Nov 23;378(6555):409–412. doi: 10.1038/378409a0. [DOI] [PubMed] [Google Scholar]
  20. Joseph C. K., Qureshi S. A., Wallace D. J., Foster D. A. MARCKS protein is transcriptionally down-regulated in v-Src-transformed BALB/c 3T3 cells. J Biol Chem. 1992 Jan 15;267(2):1327–1330. [PubMed] [Google Scholar]
  21. Li W., Mischak H., Yu J. C., Wang L. M., Mushinski J. F., Heidaran M. A., Pierce J. H. Tyrosine phosphorylation of protein kinase C-delta in response to its activation. J Biol Chem. 1994 Jan 28;269(4):2349–2352. [PubMed] [Google Scholar]
  22. Li W., Yu J. C., Shin D. Y., Pierce J. H. Characterization of a protein kinase C-delta (PKC-delta) ATP binding mutant. An inactive enzyme that competitively inhibits wild type PKC-delta enzymatic activity. J Biol Chem. 1995 Apr 7;270(14):8311–8318. doi: 10.1074/jbc.270.14.8311. [DOI] [PubMed] [Google Scholar]
  23. Liao L., Ramsay K., Jaken S. Protein kinase C isozymes in progressively transformed rat embryo fibroblasts. Cell Growth Differ. 1994 Nov;5(11):1185–1194. [PubMed] [Google Scholar]
  24. Martiny-Baron G., Kazanietz M. G., Mischak H., Blumberg P. M., Kochs G., Hug H., Marmé D., Schächtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem. 1993 May 5;268(13):9194–9197. [PubMed] [Google Scholar]
  25. McCaffrey P. G., Friedman B., Rosner M. R. Diacylglycerol modulates binding and phosphorylation of the epidermal growth factor receptor. J Biol Chem. 1984 Oct 25;259(20):12502–12507. [PubMed] [Google Scholar]
  26. Mischak H., Goodnight J. A., Kolch W., Martiny-Baron G., Schaechtle C., Kazanietz M. G., Blumberg P. M., Pierce J. H., Mushinski J. F. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem. 1993 Mar 25;268(9):6090–6096. [PubMed] [Google Scholar]
  27. Mohammadi M., Dionne C. A., Li W., Li N., Spivak T., Honegger A. M., Jaye M., Schlessinger J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature. 1992 Aug 20;358(6388):681–684. doi: 10.1038/358681a0. [DOI] [PubMed] [Google Scholar]
  28. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995 Apr;9(7):484–496. [PubMed] [Google Scholar]
  29. Noh D. Y., Shin S. H., Rhee S. G. Phosphoinositide-specific phospholipase C and mitogenic signaling. Biochim Biophys Acta. 1995 Dec 18;1242(2):99–113. doi: 10.1016/0304-419x(95)00006-0. [DOI] [PubMed] [Google Scholar]
  30. Peters K. G., Marie J., Wilson E., Ives H. E., Escobedo J., Del Rosario M., Mirda D., Williams L. T. Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis. Nature. 1992 Aug 20;358(6388):678–681. doi: 10.1038/358678a0. [DOI] [PubMed] [Google Scholar]
  31. Peterson J. E., Jelinek T., Kaleko M., Siddle K., Weber M. J. c phosphorylation and activation of the IGF-I receptor in src-transformed cells. J Biol Chem. 1994 Nov 4;269(44):27315–27321. [PubMed] [Google Scholar]
  32. Qureshi S. A., Joseph C. K., Rim M., Maroney A., Foster D. A. v-Src activates both protein kinase C-dependent and independent signaling pathways in murine fibroblasts. Oncogene. 1991 Jun;6(6):995–999. [PubMed] [Google Scholar]
  33. Seedorf K., Shearman M., Ullrich A. Rapid and long-term effects on protein kinase C on receptor tyrosine kinase phosphorylation and degradation. J Biol Chem. 1995 Aug 11;270(32):18953–18960. doi: 10.1074/jbc.270.32.18953. [DOI] [PubMed] [Google Scholar]
  34. Singer W. D., Brown H. A., Jiang X., Sternweis P. C. Regulation of phospholipase D by protein kinase C is synergistic with ADP-ribosylation factor and independent of protein kinase activity. J Biol Chem. 1996 Feb 23;271(8):4504–4510. doi: 10.1074/jbc.271.8.4504. [DOI] [PubMed] [Google Scholar]
  35. Song J. G., Pfeffer L. M., Foster D. A. v-Src increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine. Mol Cell Biol. 1991 Oct;11(10):4903–4908. doi: 10.1128/mcb.11.10.4903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Song J., Foster D. A. v-Src activates a unique phospholipase D activity that can be distinguished from the phospholipase D activity activated by phorbol esters. Biochem J. 1993 Sep 15;294(Pt 3):711–717. doi: 10.1042/bj2940711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Spangler R., Joseph C., Qureshi S. A., Berg K. L., Foster D. A. Evidence that v-src and v-fps gene products use a protein kinase C-mediated pathway to induce expression of a transformation-related gene. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7017–7021. doi: 10.1073/pnas.86.18.7017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Szallasi Z., Denning M. F., Smith C. B., Dlugosz A. A., Yuspa S. H., Pettit G. R., Blumberg P. M. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Mol Pharmacol. 1994 Nov;46(5):840–850. [PubMed] [Google Scholar]
  39. Szallasi Z., Smith C. B., Pettit G. R., Blumberg P. M. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J Biol Chem. 1994 Jan 21;269(3):2118–2124. [PubMed] [Google Scholar]
  40. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991 Aug 25;266(24):15771–15781. [PubMed] [Google Scholar]
  41. Valius M., Bazenet C., Kazlauskas A. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively. Mol Cell Biol. 1993 Jan;13(1):133–143. doi: 10.1128/mcb.13.1.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wasilenko W. J., Payne D. M., Fitzgerald D. L., Weber M. J. Phosphorylation and activation of epidermal growth factor receptors in cells transformed by the src oncogene. Mol Cell Biol. 1991 Jan;11(1):309–321. doi: 10.1128/mcb.11.1.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Yuspa S. H., Poirier M. C. Chemical carcinogenesis: from animal models to molecular models in one decade. Adv Cancer Res. 1988;50:25–70. doi: 10.1016/s0065-230x(08)60434-0. [DOI] [PubMed] [Google Scholar]
  44. Zang Q., Frankel P., Foster D. A. Selective activation of protein kinase C isoforms by v-Src. Cell Growth Differ. 1995 Nov;6(11):1367–1373. [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES